ClearPoint Neuro, Inc. (CLPT), previously known as MRI Interventions, Inc., is a global medical device and biologics company dedicated to improving and saving lives by enabling minimally invasive procedures with real-time, intra-procedural magnetic resonance imaging (MRI). With its corporate headquarters in Solana Beach, California, U.S., the company has additional offices in Irvine, California, and Knoxville, Tennessee.
ClearPoint Neuro specializes in neuro-navigation, much like how GPS guides drivers to their destination. Its groundbreaking technology, the ClearPoint Neuro Navigation System, is the only platform in the world that provides real-time visualization during neurosurgeries. Physicians can see inside the patient's brain in real-time during procedures for more precise, safer, and less invasive surgeries.
This innovative system has broad applications across various therapeutic areas, including deep brain stimulation (DBS), laser interstitial thermal therapy (LITT), biopsy, catheter and electrode placement, and more. It has revolutionized the field of neurosurgery, making surgical procedures safer and more effective, offering patients faster recovery times and better outcomes.
Furthermore, ClearPoint Neuro is at the forefront of drug delivery for neurological disorders, enhancing direct drug delivery to specific areas of the brain with its technology and proprietary biologics. This capability breaks barriers to brain treatments and allows for new possibilities in neuro-oncology and neuro-degenerative diseases, such as Alzheimer's and Parkinson's disease. This is achieved by facilitating drug companies to localize and optimize the delivery of their drugs or cells directly to critical areas of the brain.
CLPT is committed to improving the quality of life for patients living with various neurological disorders by allowing more accurate surgical procedures, minimizing trauma, reducing costs, and improving recovery times. Their innovative technology and biologics solutions have the potential to significantly advance treatment for those suffering from some of the most devastating neurological diseases, offering hope for a better quality of life. ClearPoint Neuro upholds the highest standards of safety, efficiency, and accuracy in its operations, earning the trust of physicians, patients, and families alike.
Being publicly traded on the Nasdaq under the ticker symbol "CLPT," ClearPoint Neuro continues to make strides in the medical world and introduces significant advancements at the cross-section of technology, biologics, and neuroscience. The company's efforts are pushing the boundaries of what's possible in neurosurgery and drug delivery, a testament to its dedication to improving and saving lives. Overall, ClearPoint Neuro sits at the forefront of the neurosurgical industry, pioneering innovative solutions and shaping the future of neuroscience treatment.